OMEGA HEALTHCARE INVESTORS, INC. OHI Cash Flow

Omega healthcare investors, inc. (OHI)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities
Net income
372,044	351,947	355,704	271,818	278,133	293,884	294,137	97,560	83,731	104,910	169,637	389,286	434,283	383,367	317,027	318,147	248,459	233,315	226,762	205,221	208,572	221,349	211,565	187,989	190,230	172,521	159,238	151,220	132,734	120,698	106,068	97,385	84,603	52,606	38,282	33,853	31,572	58,436	0	0	0
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
313,474	301,683	291,783	285,798	281,770	281,279	286,004	287,218	287,959	287,591	283,076	279,467	274,622	267,062	257,048	248,875	242,526	210,703	180,310	150,278	122,423	123,257	125,116	127,207	128,131	128,646	126,718	122,821	117,795	112,983	108,140	104,706	102,266	100,337	100,591	103,462	95,154	84,623	0	0	0
Impairment on real estate properties
0	-	-	-	-	35,014	95,320	90,289	96,346	99,070	35,610	35,048	31,806	58,726	61,766	46,234	46,257	17,681	0	0	0	-	-	-	-	-	-	-	-	272	1,645	1,645	1,645	26,344	24,971	24,971	25,126	155	0	0	0
Impairment on direct financing leases
-	7,917	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for credit losses
0	-	-	-	-	6,689	7,276	17,881	19,990	14,580	19,545	10,952	7,125	9,845	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest - amortization of deferred financing costs
9,787	9,564	8,990	8,951	8,955	8,960	8,966	8,956	19,452	19,711	19,969	22,058	11,530	11,458	31,387	28,927	27,527	35,827	14,718	12,487	15,268	7,500	6,879	7,952	-6,053	-8,333	-5,844	-5,870	3,514	10,569	8,028	11,055	12,788	5,745	22,017	19,295	22,978	23,262	0	0	0
Accretion of direct financing leases
0	-	-	-	0	-	-	-	3,058	6,107	9,297	12,406	12,252	12,157	11,882	11,601	11,314	11,007	10,669	10,344	10,051	9,787	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
15,436	15,359	15,399	16,440	16,489	15,987	15,969	15,879	15,524	15,212	15,024	14,825	14,756	13,790	14,567	13,093	12,301	11,133	8,704	8,527	7,939	8,592	8,079	7,566	6,753	5,942	5,919	5,895	5,909	5,942	5,975	6,010	6,043	6,037	4,973	3,903	2,851	2,211	0	0	0
Gain on assets sold - net
57,531	55,696	68,329	9,901	7,277	24,774	55,669	61,723	63,992	53,912	37,768	42,214	56,057	50,208	19,873	12,343	7,924	6,353	6,411	8,782	-20	2,863	0	0	0	-	-	-	-	11,799	0	0	0	-	-	-	-	-	-	-	-
Amortization of acquired in-place leases - net
-5,369	-5,904	-7,862	-8,816	-9,846	-10,707	-10,327	-23,389	-17,693	-11,910	-34,049	-15,699	-15,195	-13,991	20,539	18,873	16,954	13,846	5,471	5,298	4,891	4,986	5,041	5,151	5,066	5,083	5,045	4,963	5,190	5,312	5,536	5,708	9,130	6,088	0	0	0	-	-	-	0
Effective yield receivable on mortgage notes
88	173	437	701	886	1,068	1,255	1,443	1,685	1,924	2,070	1,293	495	721	1,115	2,431	3,764	4,065	4,306	4,547	3,679	2,878	2,072	1,267	1,531	1,757	1,977	2,196	2,226	2,235	2,083	1,779	1,474	1,341	0	0	0	-	-	-	-
Interest paid-in-kind
7,696	7,160	6,685	6,070	5,915	6,360	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from unconsolidated joint ventures
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-663	-151	-150	-150	-150	-92	-93	-33	-93	0	0	0
Change in operating assets and liabilities - net:
Contractual receivables
6,718	5,931	53	-2,393	-7,478	-2,368	-1,062	1,765	19,874	36,621	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of straight line mortgage interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Amortization of in-place leases
-	-	-	-	-	-	-	-	-	-	-	0	12,787	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,004	-	-303	2,047	2,029	2,264	1,324	-1,632	199	-867	502	469	-213	246	1,623	1,109	1,194	1,463	-2,343	-1,352	48	45	0	0	0
Straight-line rent receivables
40,072	46,580	50,364	54,895	58,354	61,559	58,468	32,812	27,990	25,240	25,691	47,509	43,891	42,091	39,451	37,942	40,729	36,057	31,602	26,126	20,907	20,956	22,433	23,898	26,213	26,899	26,044	25,986	24,873	25,404	22,409	19,008	15,698	12,560	14,178	13,921	16,559	11,210	0	0	0
Lease inducements
45,862	42,071	27,776	16,681	10,344	32,738	42,076	40,865	41,255	8,419	-1,989	-2,190	-2,389	-2,589	-2,589	-2,616	-3,751	-994	-994	-966	169	-2,656	-2,859	-2,757	-2,953	-3,080	3,666	3,368	3,369	3,369	3,391	3,392	3,293	3,380	-2,793	-1,926	-473	6	0	0	0
Other operating assets and liabilities
29,146	29,302	16,256	15,489	7,584	34,879	37,253	32,142	31,690	17,228	20,556	-2,982	14,075	-1,980	19,357	43,308	40,836	-2,972	-12,492	-28,573	-37,919	-11,537	-20,180	-22,212	-13,696	-8,028	4,342	4,760	7,810	-97	-3,034	2,521	5,096	7,601	-536	4,457	-3,424	-2,762	0	0	0
Operating assets and liabilities for owned and operated properties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	244	747	-2,218	-2,204	-2,221	0	0	0
Net cash provided by operating activities
582,740	553,747	556,663	547,619	556,548	499,373	499,109	530,878	518,265	577,912	594,804	602,078	610,141	624,773	583,849	543,219	473,301	449,416	400,750	363,877	362,778	337,540	339,493	325,376	300,405	279,949	251,354	235,175	216,327	208,271	197,720	187,043	180,609	169,771	176,137	168,777	157,472	157,563	0	0	0
Cash flows from investing activities
Acquisition of real estate
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of real estate or other
-	-	-	-	-	-	-	-	407,516	-	345,268	467,877	551,218	959,748	965,640	733,246	703,986	294,182	372,479	293,473	133,289	131,689	0	0	0	-	-	-	-	396,623	0	0	0	-	-	-	-	-	-	-	-
Net proceeds from sale of real estate investments
236,997	219,262	249,246	96,682	235,197	309,586	434,375	415,703	286,709	257,812	174,645	189,892	213,059	169,603	64,748	58,469	43,680	41,543	41,564	26,999	701	4,077	0	0	0	-	-	-	-	29,023	0	0	0	-	-	-	-	81	0	0	0
Cash acquired in acquisition
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in construction in progress
136,561	139,678	138,868	151,154	148,437	139,441	116,040	103,894	92,841	86,689	94,279	88,131	68,370	68,983	63,063	175,273	174,691	164,226	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in direct financing leases
-	-	-	-	-	-	-	-	-	7,183	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from direct financing lease and related trust
-	93,730	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Placement of mortgage loans
19,726	20,702	17,894	18,066	63,836	65,340	67,504	66,609	35,643	34,643	50,151	61,172	48,309	48,722	34,336	21,869	18,202	14,042	8,369	5,906	418,436	529,548	528,931	528,852	114,443	3,378	8,070	9,883	12,709	11,969	147,629	139,604	133,100	130,042	0	0	0	-	-	-	0
Collection of mortgage principal
55,375	54,529	43,855	43,437	1,780	26,088	26,083	26,032	25,993	1,529	2,884	18,597	59,996	59,975	58,483	41,675	1,383	1,359	1,304	7,197	123,140	122,984	122,832	117,770	498	485	12,680	12,678	12,684	12,684	490	354	213	74	84	86	88	78	0	0	0
Investments in unconsolidated joint ventures
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions from unconsolidated joint ventures in excess of earnings
8,155	9,079	9,139	3,821	4,694	5,471	5,616	6,173	5,468	12,175	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital improvements to real estate investments
55,451	52,892	44,939	35,245	30,427	29,824	36,898	40,088	39,163	37,766	34,356	35,520	39,126	40,471	39,651	36,858	30,337	26,397	23,387	20,906	20,187	17,917	20,299	22,402	26,353	31,347	33,062	32,536	29,779	29,436	27,691	25,686	23,257	19,597	22,379	27,140	31,211	36,025	0	0	0
Receipts from insurance proceeds
7,105	8,170	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts from insurance proceeds
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in other investments
115,987	100,312	79,183	206,474	303,885	385,707	427,756	279,781	206,863	139,047	114,633	187,249	177,698	271,557	258,912	165,338	179,937	65,402	52,219	40,662	6,844	9,441	11,171	11,786	37,752	36,655	37,261	36,427	11,636	9,737	33,330	34,772	33,980	33,504	4,845	4,370	2,707	16,436	0	0	0
Proceeds from other investments
61,994	91,281	91,390	126,012	169,869	181,371	212,769	165,394	126,388	95,696	92,352	106,863	118,509	96,789	57,925	57,588	45,177	45,871	43,065	25,450	14,677	13,589	34,801	30,365	30,259	30,962	7,647	8,257	9,065	15,355	15,618	15,276	14,063	6,983	5,790	8,522	21,843	21,324	0	0	0
Net cash (used in) provided by investing activities
-506,233	-378,953	48,864	-181,981	-99,646	-173,219	-35,637	-155,530	-302,931	-285,133	-379,091	-540,793	-423,777	-1,113,908	-1,181,525	-981,675	-1,052,664	-397,411	-437,732	-232,356	-446,089	-547,945	-990,000	-994,167	-707,758	-598,831	-232,311	-418,307	-412,191	-390,703	-465,801	-261,664	-241,941	-257,640	-46,056	-48,227	-377,540	-394,815	0	0	0
Cash flows from financing activities
Proceeds from credit facility borrowings
1,998,466	1,507,000	1,175,000	1,423,000	1,145,000	1,291,000	1,203,000	1,419,000	1,856,000	1,687,000	1,657,000	1,242,000	782,000	1,304,000	1,256,000	1,923,000	2,490,000	1,826,000	1,848,000	1,092,000	786,000	900,000	1,066,000	900,000	476,000	511,000	641,000	821,000	822,000	712,000	552,000	487,000	497,000	569,000	360,000	288,000	496,000	385,000	0	0	0
Payments on credit facility borrowings
1,957,100	1,980,100	1,820,100	1,428,100	1,305,000	1,268,000	1,208,000	1,354,000	1,624,000	1,587,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds (costs) from issuance of common stock
-	-	-	-	-	-	-	-	15,332	-	0	0	0	-	-	-	-	439,322	439,722	444,865	474,182	61,981	180,211	237,261	254,738	278,373	160,104	160,308	123,901	77,618	77,646	15,434	8,272	31,210	33,084	96,606	130,150	138,781	0	0	0
Payments for exercised options and restricted stock
-	-	-	-	-	-	-	-	-	-	-	0	23,165	-	23,941	22,104	27,181	26,706	28,163	9,616	4,953	3,577	0	0	0	-	-	-	-	-	-	-	-	1,254	3,184	3,184	761	2,019	0	0	0
Payment of financing related costs incurred by Omega
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,960,000	-	1,301,000	1,011,000	786,000	1,141,000	1,163,000	735,000	576,000	343,000	543,000	618,000	649,000	726,500	495,000	538,000	539,000	296,500	458,000	456,000	427,000	479,100	0	0	0
Noncontrolling members' contributions to consolidated joint venture
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts of other long-term borrowings
-	494,985	0	0	0	-	-	-	-	-	-	-	-	1,048,173	1,298,173	1,198,302	1,498,302	1,838,124	1,588,124	1,237,650	937,650	842,148	942,148	694,320	694,320	159,355	59,355	59,355	59,355	400,000	0	0	0	-	-	-	-	779,770	0	0	0
Payments of other long-term borrowings
0	-	-	-	-	2,049	2,374	2,698	1,252,798	1,252,788	1,252,778	1,432,768	181,258	181,249	780,185	600,343	1,839,740	2,187,314	1,592,575	1,627,645	389,189	242,544	239,256	204,924	255,883	114,642	114,447	114,220	74,676	190,686	190,414	190,051	177,996	2,593	412,432	412,340	411,728	470,478	0	0	0
Payments of financing related costs
-	-	-	-	-	8	8	723	28,643	29,198	29,258	36,732	8,817	11,830	35,782	32,179	36,979	54,721	31,106	31,099	34,879	17,716	19,500	14,942	6,583	3,234	5,027	5,236	5,413	17,124	13,219	16,584	16,288	4,305	26,584	23,396	27,822	31,579	0	0	0
Receipts from dividend reinvestment plan
86,513	115,051	101,742	73,854	74,200	46,801	43,490	44,051	34,273	36,722	40,408	166,429	227,780	240,041	314,951	214,069	165,029	150,847	70,889	55,794	45,361	71,487	74,267	60,041	51,035	55,825	53,603	84,526	134,020	111,914	110,333	87,481	55,817	59,118	158,497	128,650	65,822	60,511	0	0	0
Payments for exercised options and restricted stock
5,426	4,556	3,848	3,195	2,279	1,654	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock
330,147	404,863	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid
582,097	564,127	550,210	539,486	533,880	528,696	524,917	518,902	511,780	502,603	492,913	482,806	467,924	453,152	438,790	423,913	397,471	358,232	320,337	284,396	265,092	258,501	250,312	239,598	229,207	218,116	208,585	199,183	190,189	182,190	174,116	169,866	164,205	161,893	160,266	155,275	148,552	138,883	0	0	0
Redemption of Omega OP Units
-	-	-	-	-	134	118	118	64	48	49	771	779	733	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to Omega OP Unit Holders
21,571	21,294	22,934	23,861	24,621	23,493	23,452	23,248	22,957	22,626	22,260	21,971	21,602	21,179	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Redemption of preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108,556	0	0	0	-	-	-	0
Net cash provided by (used in) financing activities
233,788	-153,959	-573,833	-344,409	-493,752	-410,701	-486,930	-395,320	-189,565	-303,815	-228,397	-76,065	-158,182	576,296	600,500	432,258	-125,514	-65,316	51,958	-135,097	763,080	212,278	583,202	690,441	402,116	319,787	41,763	187,310	218,758	183,792	264,302	72,486	60,668	81,299	-120,543	-117,511	148,255	242,003	0	0	0
Effect of foreign currency translation on cash, cash equivalents and restricted cash
327	874	-601	-640	-849	-590	-317	287	783	568	424	448	351	84	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in cash, cash equivalents and restricted cash
310,622	21,709	31,093	20,589	-37,699	-85,137	-23,775	-19,685	26,552	-10,468	-12,260	-14,332	28,533	87,245	0	0	0	-	-	-	679,769	1,873	-67,305	21,650	-5,237	905	60,806	4,178	22,894	1,360	-3,779	-2,135	-664	-6,570	9,538	3,039	-71,813	4,751	0	0	0
Interest paid during the period, net of amounts capitalized
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	156,697	-	125,179	121,614	110,505	110,919	101,144	99,697	100,867	100,716	100,566	99,915	98,770	94,841	93,440	87,135	84,466	79,199	74,408	77,168	69,372	60,290	0	0	0
Taxes paid during the period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Change in fair value of cash flow hedges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued Dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash settlement of mortgage obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12,395	0	0	0
Non-cash acquisition of real estate properties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12,395	0	0	0
Common stock subscription
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Omega OP
Net income
372,044	351,947	355,704	271,818	278,133	293,884	294,137	97,560	83,731	104,910	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
313,474	301,683	291,783	285,798	281,770	281,279	286,004	287,218	287,959	287,591	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment on real estate properties
0	-	-	-	-	35,014	95,320	90,289	96,346	99,070	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment on direct financing leases
-	7,917	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for credit losses
0	-	-	-	-	6,689	7,276	17,881	19,990	14,580	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest - amortization of deferred financing costs
9,787	9,564	8,990	8,951	8,955	8,960	8,966	8,956	19,452	19,711	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of direct financing leases
0	-	-	-	0	-	-	-	3,058	6,107	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
15,436	15,359	15,399	16,440	16,489	15,987	15,969	15,879	15,524	15,212	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on assets sold - net
57,531	55,696	68,329	9,901	7,277	24,774	55,669	61,723	63,992	53,912	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of acquired in-place leases - net
-5,369	-5,904	-7,862	-8,816	-9,846	-10,707	-10,327	-23,389	-17,693	-11,910	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effective yield receivable on mortgage notes
88	173	437	701	886	1,068	1,255	1,443	1,685	1,924	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid-in-kind
7,696	7,160	6,685	6,070	5,915	6,360	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from unconsolidated joint ventures
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contractual receivables
6,718	5,931	53	-2,393	-7,478	-2,368	-1,062	1,765	19,874	36,621	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Straight-line rent receivables
40,072	46,580	50,364	54,895	58,354	61,559	58,468	32,812	27,990	25,240	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease inducements
45,862	42,071	27,776	16,681	10,344	32,738	42,076	40,865	41,255	8,419	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other operating assets and liabilities
29,146	29,302	16,256	15,489	7,584	34,879	37,253	32,142	31,690	17,228	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
582,740	553,747	556,663	547,619	556,548	499,373	499,109	530,878	518,265	577,912	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of real estate
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of real estate or other
-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from sale of real estate investments
236,997	219,262	249,246	96,682	235,197	309,586	434,375	415,703	286,709	257,812	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in construction in progress
136,561	139,678	138,868	151,154	148,437	139,441	116,040	103,894	92,841	86,689	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in direct financing leases
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from direct financing lease and related trust
-	93,730	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Placement of mortgage loans
19,726	20,702	17,894	18,066	63,836	65,340	67,504	66,609	35,643	34,643	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collection of mortgage principal
55,375	54,529	43,855	43,437	1,780	26,088	26,083	26,032	25,993	1,529	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in unconsolidated joint ventures
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions from unconsolidated joint ventures in excess of earnings
8,155	9,079	9,139	3,821	4,694	5,471	5,616	6,173	5,468	12,175	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital improvements to real estate investments
55,451	52,892	44,939	35,245	30,427	29,824	36,898	40,088	39,163	37,766	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts from insurance proceeds
7,105	8,170	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts from insurance proceeds
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in other investments
115,987	100,312	79,183	206,474	303,885	385,707	427,756	279,781	206,863	139,047	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from other investments
61,994	91,281	91,390	126,012	169,869	181,371	212,769	165,394	126,388	95,696	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by investing activities
-506,233	-378,953	48,864	-181,981	-99,646	-173,219	-35,637	-155,530	-302,931	-285,133	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of secured borrowings
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from intercompany loans payable from Omega
2,488,901	1,999,710	1,669,985	1,425,275	1,147,275	1,291,000	1,203,000	1,419,000	3,202,749	3,033,749	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of intercompany loans payable to Omega
2,032,100	2,055,100	1,920,100	1,428,100	1,306,721	1,270,049	1,210,374	1,356,698	2,876,798	2,839,788	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of financing related costs incurred by Omega
-	-	-	-	-	8	8	723	28,643	29,198	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncontrolling members' contributions to consolidated joint venture
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity contributions from general partners
411,234	515,358	253,268	221,551	224,029	120,679	68,939	85,369	47,928	56,699	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to general partners
582,097	564,127	550,210	539,486	533,880	528,696	524,917	518,902	511,780	502,603	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to limited partners
21,571	21,294	22,934	23,861	24,621	23,493	23,452	23,248	22,957	22,626	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Redemption of Omega OP Units
-	-	-	-	-	134	118	118	64	48	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
233,788	-153,959	-573,833	-344,409	-493,752	-410,701	-486,930	-395,320	-189,565	-303,815	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of foreign currency translation on cash, cash equivalents and restricted cash
327	874	-601	-640	-849	-590	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash, cash equivalents and restricted cash
310,622	21,709	31,093	20,589	-37,699	-85,137	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-